Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01552798 · ClinicalTrials.gov registry record · Phase 3
Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache
A Phase 3 study, sponsored by Bayer.
- Terminated
- Registry status
- Phase 3
- Development phase
- 9
- Enrollment target
NCT01552798 is a Phase 3 study that was terminated before completion, run by Bayer. The registered enrollment target is 9 participants.
The verdict
NCT01552798, a Phase 3 study, was terminated before completion, sponsored by Bayer.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine if a single, oral dose of a fast release aspirin 1000 mg provides relief compared to acetaminophen 1000 mg and placebo in subjects with tension-type headache pain.
Interventions
- DRUG Placebo
- DRUG Acetaminophen
- DRUG Acetylsalicylic acid (Aspirin, BAY1019036)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-03-12 |
| Est. Completion | 2012-06-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01552798
The ClinicalTrials.gov registry entry for NCT01552798 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01552798 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01552798 about?
NCT01552798 is a clinical study titled "Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type Headache". The purpose of this trial is to determine if a single, oral dose of a fast release aspirin 1000 mg provides relief compared to acetaminophen 1000 mg and placebo in subjects with tension-type headache pain.
What is the current status of trial NCT01552798?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 9 participants. The study started on 2012-03-12. Estimated completion is 2012-06-04.
What interventions are being tested in trial NCT01552798?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG), Acetylsalicylic acid (Aspirin, BAY1019036) (DRUG).
Who is sponsoring clinical trial NCT01552798?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.